EnsoData provides software-as-a-service (SaaS) that enables the discovery, identification, and actionable reporting of critical to understand patterns and trends in health data.
EnsoData’s technology unlocks the vast wealth of clinical expertise lying dormant in archived data; by their leveraging big data and analytics engine, EnsoData enables software to automatically perform complex and time consuming data interpretation previously left to clinicians. Their first product, EnsoSleep, uses big data and advanced algorithms to automate the scoring of sleep studies.
EnsoData’s technology unlocks the vast wealth of clinical expertise lying dormant in archived data; by their leveraging big data and analytics engine, EnsoData enables software to automatically perform complex and time consuming data interpretation previously left to clinicians. Their first product, EnsoSleep, uses big data and advanced algorithms to automate the scoring of sleep studies.
Location: United States
Employees: 11-50
Phone: +1 608-509-4704
Total raised: $50.5M
Founded date: 2015
Investors 6
| Date | Name | Website |
| - | Necessary ... | necessary.... |
| - | DreamIt Ve... | dreamit.co... |
| - | HealthX Ve... | healthxven... |
| - | Sachse fam... | sachse.vc |
| - | Sachse fam... | sachsefami... |
| - | Colle Capi... | colle.vc |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 22.11.2025 | Series B | $20M | - |
| 04.06.2022 | Series A | $20M | - |
| 11.06.2020 | - | $9M | - |
| 02.03.2018 | Seed | $1.5M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Grayson | Judge | Investor, ... | linkedin.c... | - | - |
Mentions in press and media 25
| Date | Title | Description |
| 13.05.2026 | EnsoData Secures Growth Capital From CIBC Innovation Banking | CIBC Innovation Banking announced it has provided growth capital financing to EnsoData, a healthcare technology company focused on advancing sleep medicine through artificial intelligence solutions. The financing is expected to support Enso... |
| 13.05.2026 | EnsoData Receives Investment From CIBC Innovation Banking | EnsoData, a Madison, WI-based provider of AI-powered software solutions for sleep medicine, received an investment from CIBC Innovation Banking. The amount of the deal was not disclosed. The company intends to use the funds to expand operat... |
| 22.11.2025 | EnsoData™ raises $20M Series B to Expand Commercial Team | - |
| 27.08.2024 | EnsoData and Nonin Partner to Offer Sleep Labs New Home Sleep Testing Solution | - |
| 20.02.2024 | FDA approves sleep apnea tech from EnsoData, Samsung | - |
| 18.05.2023 | EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide | Now that we have helped clinicians read one million studies and reach one million patients, we’re only doubling down on our mission to positively impact patient care and make healthcare more accessible and affordable – to reach the next 10 ... |
| 09.05.2023 | EnsoData Ranks Among Highest-Scoring Businesses on Inc. Magazine’s Annual List of Best Workplaces for 2023 | “Our people are what makes EnsoData tick. Without their absolute dedication and passion to make healthcare better, none of it would work,” said Chris Fernandez, co-founder, Executive Chairman, Chief Research Officer of EnsoData. MADISON, Wi... |
| 01.11.2022 | EnsoData Appoints Dr. Nathaniel Watson as New Chief Medical Officer | Dr. Nathaniel Watson, EnsoData's new Chief Medical Officer “In this new role, I’m excited to advance the sleep health care discussion with payors, employers, providers and patients to optimize systems to affordably maximize the populations’... |
| 03.06.2022 | Carlyle’s CEO says he is on alert as recession looms | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Carlyle Group CEO Kewsong Lee wants everyone to know that he isn’t concerned—but he’s certainly o... |
| 03.06.2022 | EnsoData Closes $20M Series A Extension Funding | EnsoData, a Madison, WI-based AI health care company helping clinicians uncover disease while patients sleep, closed a $20m Series A extension funding. The round was led by Inspire Medical Systems, Inc. (NYSE: INSP), with participation from... |
Show more